Enzalutamide for Bladder Cancer Chemoprevention

NCT02605863 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low enrollment, sponsor withdrew support for study

Conditions

Bladder Cancer

Interventions

DRUG: Enzalutamide

Sponsor

University of Rochester

Collaborators

[object Object]